Patients with nonalcoholic fatty liver (NAFLD) are typically obese and confounded by the
metabolic syndrome. The body mass index (BMI) is often used as a surrogate marker of …

The underlying mechanism and pathogenesis of NAFLD remain elusive. Although research
effort has advanced the understanding of the natural history, pathogenesis and …

Because of the global obesity epidemic, the incidence and prevalence of nonalcoholic fatty
liver disease (NAFLD) have increased worldwide, including among Koreans. Recently, the …

Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world.
Presentation of the disease ranges from simple steatosis to non-alcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) is often thought of as the hepatic manifestation of
the metabolic syndrome and is frequently accompanied by type 2 diabetes, hypertension …

To date, a majority of studies have focused on obese nonalcoholic fatty liver disease
(NAFLD), which is mainly responsible for the Western NAFLD population. Nevertheless, a …

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide, associated with a high risk of progression to NASH, liver cirrhosis and …

The ongoing obesity epidemic and the increasing recognition of metabolic syndrome have
contributed to the growing prevalence of nonalcoholic fatty liver disease (NAFLD), the most …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excess
fat accumulation in the liver. It is closely associated with metabolic syndrome, and patients …